ARTICLE
9 February 2018

Mintz Levin's Health Care Enforcement Defense Group Releases New Qui Tam Update

M
Mintz

Contributor

Mintz is a general practice, full-service Am Law 100 law firm with more than 600 attorneys. We are headquartered in Boston and have additional US offices in Los Angeles, Miami, New York City, San Diego, San Francisco, and Washington, DC, as well as an office in Toronto, Canada.
This Update analyzes the 47 health care-related qui tam cases unsealed in August and September 2017.
United States Food, Drugs, Healthcare, Life Sciences

Mintz Levin's  Health Care Enforcement Defense Group recently published its most recent Health Care Qui Tam Update. This Update analyzes the 47 health care-related qui tam cases unsealed in August and September 2017.  Highlights from this Update include:

  • a relatively high rate of intervention;
  • cases filed in 30 different courts;
  • cases brought against a variety of different health care providers;
  • almost half of the cases filed by current or former employees; and
  • faster times for unsealing cases.

The Update also provides an in-depth look at three sets of cases, including a set of seven qui tam actions filed against pharmaceutical manufacturer Novo Nordisk Inc. for alleged false claims stemming from "off-label" marketing of Victoza (liraglutide).

Click  here to read the full Update.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More